Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in Brain & Development
- Vol. 19 (6) , 398-402
- https://doi.org/10.1016/s0387-7604(97)00046-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Concentration‐Effect and Concentration‐Toxicity Relations with Lamotrigine: A Prospective StudyEpilepsia, 1996
- Lamotrigine in Treatment of 120 Children with EpilepsyEpilepsia, 1994
- Lamotrigine in Resistant Childhood EpilepsyNeuropediatrics, 1993
- Outcomes of Add‐on Treatment with Lamotrigine in Partial EpilepsyEpilepsia, 1993
- Lamotrigine as an Add-On Drug in the Management of Lennox-Gastaut SyndromeEuropean Neurology, 1992
- A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizuresEpilepsy Research, 1990
- A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsyEpilepsy Research, 1990
- Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsyEpilepsy Research, 1989
- Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial SeizuresEpilepsia, 1989
- Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic DrugEpilepsia, 1986